Bibliografía

2. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-60.

3. Alexopoulos E, Vakianis P, Kokolina E et al. Acute renal failure in a medical setting: changing patterns and prognostic factors. Ren Fail 1994; 16: 273-84.

4. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community-based study. BMJ 1993; 306: 481-483.

5. Rose B.D. and Black R.M. Manual of Clinical Problems in Nephrology. Litle, Brown & Company (Boston, Mass.), 1988.

6. Miller RB, Tassistro CR: Peritoneal dialysis. N Engl J Med 281:945-949, 1969.

7. Brady HR, Singer GG. Acute renal failure. Lancet 1995; 346: 1533-40.

8. Brenner B.M., Rector F.C. El Riñón. Edit. Médica panamérica S.A. 1989.

9. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous hemofiltration: A new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 1997; 55: 1121-1122.

10. Forni LG, Hilton PJ. Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 1997; 336: 1303-9.

11. Barton IK, Hilton PJ. Veno-venous haemofiltration in the intensive care unit. Clin Intensive Care 1993; 4: 16-22.

12. Bellomo R, Boyce N. Acute continuous hemodiafiltration: a prospective study of 110 patients and a review of the literature. Am J Kidney Dis 1993; 21: 508-18.

13. Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 1984; 30: 160.

14. Schäfer GE, Döring C, Sodemann K, Russ A, Schroder HM. Continuous arteriovenous and venovenous hemodyalisis in critically ill patients. Contrib Nephrol 1991; 93: 23-8.

15. Ronco C, Bellomo R, Wratten ML, Tetta C. Today´s technology for continuous renal replacement therapies. Clin Intensive Care 1996; 7: 198-205.

16. Lauer A, Saccaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP. Continuous arteriovenous hemofiltration in the critically ill patient: clinical use and operational characteristics. Ann Intern Med 1983; 99: 455-60.

17. Van Geelen JA, Vincent HH, Schalekamp MADH. Continuous arteriovenous haemofiltration and haemodiafiltration in acute renal failure. Nephrol Dial Transplant 1988; 3: 181-6.

18. Journois D, Chanu D, Pouard P, Mauriat P, Safran D. Assessment of standarized ultrafiltrate production rate using protacyclin in continuous venovenous hemofiltration. Contrib Nephrol 1991; 93: 202-4.

19. Miller LC, Hall JC, Crow JW, Cato AE, Edson JR, Scheinman JI. Hemodialysis in heparin-associated thrombocytopenia: epoprostenol (PGI2) as sole anticoagulant. Dial Transplant 1985; 14: 579-80.

20. Swartz RD, Flamenbaum W, Dubrow A, Hall JC, Crow JW, Cato A. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol 1988; 28: 818-25.

21. Barton IK, Hilton PJ, Trecher DF, Bradley RD. Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. Nephrol Dial Transplant 1991; 6 (5): 368-370.

22. Byrick RJ, Goldstein MB, Wong PY. Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit Care Med 1992; 20: 1483-6.

23. Rimondini L. Hemofiltration as short term treatment for refractory congestive heart failure. Am J Med 1987; 83: 43-8.

24. Simpson IA. Ultrafiltration in the management of refractory congestive heart. Br Heart J 1986; 5: 311-17.

25. Baudouin SV, Wiggins J, Keogh BF et al. Continuous venovenous hemofiltration following cardio-pulmonary bypass. Intensive Care Med 1993; 19: 290-3.

26. Lamer C, Valleaux T, Plaisance P et al. Continuous arteriovenous hemodialysis for acute renal failure after cardiac operations. J Thorac Cardiovasc Surg 1990; 99: 175-6.

27. Gomez A, Wang R, Unruth H et al. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73: 671-85.

28. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-6.

29. Díaz-Regañón Valverde G, Fernández Rico R, Martínez Jiménez C, Ortiz Piquer M, García Castillo L, González Herrera S. La hemofiltración arteriovenosa continua en el tratamiento del síndrome de distrés respiratorio del adulto y del síndrome de disfunción multiorgánica. Med Intensiva 1995; 19: 449-453.

30. Ronco C. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clinical Nephrology 1993; 40 (4): 187-198.

31. Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy DW. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991; 18: 451-8.

32. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413-20.

33. Barton IK, Hilton PJ, Treacher DF, Bradley RD. Treatment of combined acute renal failure and lactic acidosis by hemofiltration. Clin Intensive Care 1992; 3: 196-8.

34. Grupos de trabajo de toxicología de la ACMI (GITAB) y de la SEMIUC (GT-TOX). Recomendaciones de la indicación de depuración renal y extrarrenal en las intoxicaciones agudas. Med Intensiva 1997; 21: 156-166.

35. Corwin HL, Teplick RS, Schreiber MJ, et al: Prediction of outcome in acute renal failure. Am J Nephrol 1987; 7:8-12.

36. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995; 155: 1505-11.

37. McDonald BR, Mehta RL. Decreased mortality in patients with acute renal failure undergoing continuous arteriovenous hemodialysis. Contrib Nephrol 1991; 93: 51-6.

38. Van Bommel EFH, Bouvy ND, So KL, et al. Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 1995; 15: 192-200.